Phenotypical aspects and clinical course of multiple sclerosis in 76 patients with a North African ethnic background followed at the Nice University Hospital;Caractéristiques phénotypiques et évolutives de la SEP chez des patients originaires du Maghreb et suivis au CHRU de Nice (à propos d'une cohorte de 76 patients)

Revue Neurologique

Volumn 163, Issue 4, 2007, Pages 440-447

  Jeannin, S ^a   Bourg, V ^a   Berthier, F ^a   Lebrun, C ^a,b  

^a PASTEUR HOSPITAL   (France)

^b UNIVERSITY HOSPITAL OF NICE   (France)

Author keywords

Course; Immigration; Immunosuppressive agents; Multiple Sclerosis; North Africa

Indexed keywords

ADULT; ARTICLE; BIRTHPLACE; BRAIN DAMAGE; BRAIN STEM; CEREBELLUM DISEASE; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DATA BASE; DELAYED DIAGNOSIS; DESCRIPTIVE RESEARCH; DISEASE COURSE; ETHNICITY; FEMALE; FRANCE; GENDER; HUMAN; IMMIGRANT; MAJOR CLINICAL STUDY; MALE; MOTOR DYSFUNCTION; MULTIPLE SCLEROSIS; NEUROLOGY; NORTH AFRICA; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PATIENT ASSESSMENT; PHENOTYPE; PROGNOSIS; REMISSION; RETROSPECTIVE STUDY; SPINAL CORD; STATISTICAL ANALYSIS; UNIVERSITY HOSPITAL; VISUAL DISORDER; AFRICA; AGE; AGED; ETHNIC GROUP; ETHNOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; SEX DIFFERENCE; SURVIVAL;

ADULT; AFRICA, NORTHERN; AGE FACTORS; AGE OF ONSET; AGED; BRAIN STEM; CEREBELLAR DISEASES; DISEASE PROGRESSION; ETHNIC GROUPS; FEMALE; FRANCE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PROGNOSIS; RETROSPECTIVE STUDIES; SEX FACTORS; SPINAL CORD; SURVIVAL ANALYSIS;

EID: 34250003819     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0035-3787(07)90419-1     Document Type: Article

References (20)

1. AL ZEMMOURI K, YAHIAOUI M, EL A LAOUI M, CHKILI T, MEDJEL A. (1980). La sclerose en plaques au Maroc. Mar med, 11(4) : 419-426.
2. ANIBA K, LOUHAB N, HAMDI J, KISSANI N. (2004). Profile of multiple sclerosos in South Morocco. Eur Neurol, 11(Suppl.2): 183-331. EFNS P2316.
3. BARKHOF F, FILIPPI M, MILLER DH et al. (1997). Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain, 120: 2059-2069.
4. BEN HAMIDA M. (1977). La sclérose en plaques en Tunisie : Étude clinique de 100 observations. Rev Neurol, 133(2) : 109-117.
5. CONFAVREUX C, AIMAERT G, DEVIC M. (1980). Course and prognosis of multiple sclerosis assessed by the computerized data processing of 349 patients. Brain, 103(2): 281-300.
6. DEBOUVERIE M. (2005). Relation entre le phenotype de la SEP et l'origine ethnique en Lorraine. À propos de la population d'origine maghrébine. Rev Neurol, 161(4) : 2S201.
7. DRAI R, AMRAR Z, BAADOUD N et al. (2005). Estimation de la prevalence de la sclérose en plaques dans la ville de Blida-Algérie. Rev neurol, 161(4) : F9.
8. EDAN G, COUSTANS M. (1999). Évolution et surveillance de la sclérose en plaques. Rev Prat, 49(7) : 1866-1871.
9. FERRIBY D, DE SEZE J, CRETON H et al. (2004). Patients Nord-Africains et Européens atteints de sclerose en plaques: comparaison des données cliniques et paracliniques. Rev Neurol, 160(4) : F11.
10. GRANIERI E, ROSATI G, TOLA R et al. (1983). The frequency of multiple sclerosis in Mediterranean Europe. An incidence and prevalence study in Barbagia, Sardinia, insular Italy. Acta Neurol Scand, 68(2): 84-89.
11. KURTZKE JF. (1975). A reassessment of the distribution of multiple sclerosis. Acta Neurol Scand, 51: 110-157.
12. KURTZKE JF, DELASNERIE-LAUPRETRE N, WALLIN MT. (1998). Multiple sclerosis in North African migrants to France. Acta Neurol Scand, 98(5): 302-309.
13. KURTZKE JF. (2000). Multiple sclerosis in time and space-geographic clues to cause. J Neurovirol, 6Suppl 2: S134-S140.
14. MC DONALD WI, COMPSTON A, EDAN G et al. (2001). Recommanded diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol, 50: 121-127.
15. MERLE H, CABRE P, POMAN G, GERARD M, SMADJA D. (2001). Atteinte optique dans la sclérose en plaques. Résultats d'une étude transversale chez 57 patients.martiniquais. J Fr Ophtalmol, 24(8) : 829-835.
16. POSER CM, PATY DW, SCHEINBERG L et al. (1983). New Diagnostic Criteria for Multiple Sclerosis: Guideline for Research Protocols. Ann Neurol, 13: 227-231.
17. PUGLIATTI M, SOLINAS G, SOTGIU S, CASTIGLIA P, ROSATI G. (2002). Multiple sclerosis distribution in northern Sardinia: spatial cluster analysis of prevalence. Neurology, 58(2): 277-282.
18. ROXBURGH RH, SEAMAN SR, MASTERMAN T et al. (2005). Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity. Neurology, 64(7): 1144-1151.
19. VASSALLO L, ELIAN M, DEAN G. (1979). Multiple sclerosis in southern Europe. II: Prevalence in Malta in 1978. J Epidemiol Commnunity Health, 33(2): 111-113.
20. VUKUSIC S, MOREAU T, BOUHOUR F, ADELEINE P, CONFAVREUX C. (2001). Sclérose en plaques : évolution spontannée, histoire naturelle. Rev Neurol, 157(8-9 Pt1) : 753-756.